Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | CCR6 | P51684 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11616346 | 1.00 | ALDH1A1 (0.52) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL19610472 | 0.93 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL19610473 | 0.93 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL9214480 | 0.91 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| Ethylenediamine SCHEMBL4383697 | 0.91 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL11001960 | 0.87 | — | — | |
| SCHEMBL10499504 | 0.87 | — | — | |
| SCHEMBL6372267 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL6210788 | 0.85 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2DPP4MAPTPOLB | |
| SCHEMBL8094796 | 0.85 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2DPP4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117114-A1 | Method of Improving Performance of Relative Permeability Modifiers | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2026-04-30 | — | — | US | claimed |
| CN-118086986-A | High-coverage electroplated copper additive composition for printed circuit board | 广东利尔化学有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117624111-A | Process for the continuous preparation of cyclic carbonates | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-113966319-B | Synthesis of base oils by ion catalyst oligomerization and anhydrous separation of oligomerization catalysts | 雪佛龙美国公司 | 2023-12-19 | — | — | CN | claimed |
| WO-2023235841-A1 | POLYMER BACKSIDE FILM LAYER FOR MITIGATING SUBSTRATE WARPAGE | AVIENT CORPORATION (US) | 2023-12-07 | — | — | WO | claimed |
| US-11753355-B2 | Base oil synthesis via ionic catalyst oligomerization and waterless separation of the oligomerization catalyst | CHEVRON U.S.A. INC. (US) | 2023-09-12 | — | — | US | claimed |
| EP-3962883-A1 | BASE OIL SYNTHESIS VIA IONIC CATALYST OLIGOMERIZATION AND WATERLESS SEPARATION OF THE OLIGOMERIZATION CATALYST | Chevron U.S.A. Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| EP-3963031-A1 | BASE OIL FROM NAO VIA IONIC CATALYST OLIGOMERIZATION AND HYDROISOMERIZATION | Chevron U.S.A. Inc. (US) | 2022-03-09 | — | — | EP | claimed |
| US-20220041526-A1 | BASE OIL SYNTHESIS VIA IONIC CATALYST OLIGOMERIZATION AND WATERLESS SEPARATION OF THE OLIGOMERIZATION CATALYST | CHEVRON U.S.A. INC. | 2022-02-10 | — | — | US | claimed |
| CN-113966319-A | Base oil synthesis by ionic catalyst oligomerization and oligomerization catalyst anhydrous separation | 雪佛龙美国公司 | 2022-01-21 | — | — | CN | claimed |
| US-4426375-A | DIALLYLAMINE DERIVATIVES | L'OREAL (FR) | 1984-01-17 | — | — | US | claimed |
| EP-0002908-B1 | HYDROFORMYLATION OF FORMALDEHYDE WITH RHODIUM CATALYST | MONSANTO COMPANY (US) | 1982-05-12 | — | — | EP | claimed |
| US-4322391-A | DISSOLVING IN AN ORGANIC AMIDE, HYDROCHLORIC ACID SOLUTION, PRECIPITATION AND FILTRATION | BRISTOL-MYERS COMPANY (US) | 1982-03-30 | — | — | US | claimed |
| US-4317743-A | WALLS OF AN IMPERVIOUS ISOCYANATO HYDROLYZED AMIDINE PRODUCT; PRESSURE SENSITIVE ELEMENTS | WALLACE BUSINESS FORMS, INC. (US) | 1982-03-02 | — | — | US | claimed |
| US-4306062-A | TRANSESTERIFICATION WITH AN ALKENYL ESTER OF A FATTY ACID | TALRES DEVELOPMENT (N.A.) N.V. (AN) | 1981-12-15 | — | — | US | claimed |
| EP-0002735-B1 | PROCESS FOR THE PREPARATION OF PIPERONYLIDENECROTON AMIDES | HAARMANN & REIMER GMBH (DE) | 1980-12-10 | — | — | EP | claimed |
| US-4209446-A | FROM PIPERONAL AND A CROTONIC AMIDE IN PRESENCE OF ALKALI METAL HYDROXIDE AND DIPOLAR APROTIC DILUENT | HAARMAN & REIMER GMBH (DE) | 1980-06-24 | — | — | US | claimed |
| EP-0002908-A1 | Hydroformylation of formaldehyde with rhodium catalyst | MONSANTO COMPANY (US) | 1979-07-11 | — | — | EP | claimed |
| EP-0002735-A2 | Process for the preparation of piperonylidenecroton amides | HAARMANN & REIMER GMBH (DE) | 1979-07-11 | — | — | EP | claimed |
| US-4124749-A | Aryl mercury containing polymers | ALLIED CHEMICAL CORPORATION (US) | 1978-11-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117114-A1 | Method of Improving Performance of Relative Permeability Modifiers | MYH10, MYH14, NIM1K | ALDH1A1 4375/4885SMN1; SMN2 1040/4885DPP4 4851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.